Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291994 | PMC |
| http://dx.doi.org/10.1016/j.nut.2021.111421 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Eicosapentanoic Acid Supplementation for Atherosclerotic Cardiovascular Disease Prevention.
Circulation
August 2024
Division of Cardiovascular Disease, University of Alabama at Birmingham.
Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: is there a role for fibrates?
Eur J Prev Cardiol
November 2024
Lipoapheresis Unit and Reference Center for Inherited Dyslipidemias, Fondazione Toscana Gabriele Monasterio, Via Moruzzi, 1, 56124 Pisa, Italy.
Is it Time for a Genuine Placebo-controlled Trial on Effects of Vitamin D?
J Clin Endocrinol Metab
December 2024
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark.
Re-Esterified Triglyceride ω-3 Fatty Acids in Dry Eye Disease With Meibomian Gland Dysfunction: A Randomized Clinical Trial.
JAMA Ophthalmol
July 2024
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Importance: Taking ω-3 supplements has been associated with a reduction in symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD). However, a recent relatively large clinical trial concluded that treating DED with ω-3 consumption was ineffective, potentially warranting additional investigations.
Objectives: To investigate the effect of re-esterified triglyceride (rTG) ω-3 fatty acid supplementation on DED associated with MGD.
Interaction between diet and genetics in patients with inflammatory bowel disease.
World J Gastroenterol
March 2024
Department of Medicine, University Hospital of the Federal University of Juiz de Fora, University of Juiz de Fora School of Medicine, Juiz de Fora 36036-247, Minas Gerais, Brazil.
In this editorial, we comment on the article by Marangoni , published in the recent issue of the 2023; 29: 5618-5629, about "Diet as an epigenetic factor in inflammatory bowel disease". The authors emphasized the role of diet, especially the interaction with genetics, in promoting the inflammatory process in inflammatory bowel disease (IBD) patients, focusing on DNA methylation, histone modifications, and the influence of microRNAs. In this editorial, we explore the interaction between genetics, gut microbiota, and diet, in an only way.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!